STOCK TITAN

[Form 4] Sensient Technology Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 filing overview – Sensient Technologies Corp. (SXT)

Director Deborah McKeithan-Gebhardt reported a routine change to her equity position on 30 June 2025. The transaction involved the acquisition of 83.054 deferred stock units under the company’s Directors’ Deferred Compensation Plan. These units convert to common stock on a one-for-one basis and will be issued when the director’s board service ends.

Following the transaction, McKeithan-Gebhardt’s total beneficial ownership stands at 16,280.531 shares of common stock held directly and 5,468.395 deferred stock units, for an aggregated exposure of roughly 21,749 shares. No common shares were bought or sold in the open market, and no cash consideration was exchanged; the additional units reflect fee deferral rather than a discretionary share purchase.

The filing does not disclose any option grants, sales, or derivative disposals, and there are no indications of material changes to the insider’s overall ownership percentage or to the company’s capital structure. Given the small size of the award (≈0.002% of SXT’s ~45 million shares outstanding), the transaction is considered routine and non-material from a liquidity or control standpoint. However, the directionally positive addition may still be interpreted by some investors as a signal of ongoing board alignment with shareholder interests.

Panoramica della presentazione del Modulo 4 – Sensient Technologies Corp. (SXT)

La direttrice Deborah McKeithan-Gebhardt ha segnalato una modifica di routine alla sua posizione azionaria in data 30 giugno 2025. L’operazione ha riguardato l’acquisizione di 83.054 unità azionarie differite nell’ambito del Piano di Compensazione Differita per i Direttori della società. Queste unità si convertono in azioni ordinarie con un rapporto uno a uno e verranno emesse al termine del mandato della direttrice nel consiglio.

Dopo questa operazione, la proprietà effettiva totale di McKeithan-Gebhardt ammonta a 16.280,531 azioni ordinarie detenute direttamente e 5.468,395 unità azionarie differite, per un’esposizione complessiva di circa 21.749 azioni. Non sono state acquistate o vendute azioni ordinarie sul mercato aperto e non è stato scambiato denaro; le unità aggiuntive riflettono un differimento delle compensazioni piuttosto che un acquisto discrezionale di azioni.

La dichiarazione non riporta alcuna concessione di opzioni, vendite o disposizioni di strumenti derivati, né indica cambiamenti significativi nella percentuale complessiva di proprietà dell’insider o nella struttura del capitale della società. Considerando la piccola entità dell’assegnazione (circa lo 0,002% delle circa 45 milioni di azioni in circolazione di SXT), l’operazione è considerata di routine e non rilevante dal punto di vista della liquidità o del controllo. Tuttavia, questo incremento positivo può comunque essere interpretato da alcuni investitori come un segnale di allineamento continuo del consiglio con gli interessi degli azionisti.

Resumen de la presentación del Formulario 4 – Sensient Technologies Corp. (SXT)

La directora Deborah McKeithan-Gebhardt reportó un cambio rutinario en su posición accionaria el 30 de junio de 2025. La transacción consistió en la adquisición de 83.054 unidades diferidas de acciones bajo el Plan de Compensación Diferida para Directores de la empresa. Estas unidades se convierten en acciones ordinarias en una proporción uno a uno y se emitirán al finalizar el servicio de la directora en el consejo.

Tras la transacción, la propiedad beneficiaria total de McKeithan-Gebhardt es de 16.280,531 acciones ordinarias poseídas directamente y 5.468,395 unidades diferidas, sumando una exposición agregada de aproximadamente 21.749 acciones. No se compraron ni vendieron acciones ordinarias en el mercado abierto, y no hubo intercambio de efectivo; las unidades adicionales reflejan un diferimiento de honorarios y no una compra discrecional de acciones.

La presentación no revela concesiones de opciones, ventas o disposiciones de derivados, y no hay indicios de cambios materiales en el porcentaje general de propiedad del insider ni en la estructura de capital de la empresa. Dado el pequeño tamaño del otorgamiento (≈0,002% de las aproximadamente 45 millones de acciones en circulación de SXT), la transacción se considera rutinaria y no material desde el punto de vista de liquidez o control. Sin embargo, esta adición positiva puede ser interpretada por algunos inversores como una señal de alineación continua del consejo con los intereses de los accionistas.

Form 4 제출 개요 – Sensient Technologies Corp. (SXT)

이사 Deborah McKeithan-Gebhardt2025년 6월 30일에 자신의 주식 보유 변동 사항을 정기적으로 보고했습니다. 이번 거래는 회사의 이사 지연 보상 계획에 따라 83.054개의 지연 주식 단위 취득을 포함합니다. 이 단위들은 1:1 비율로 보통주로 전환되며, 이사의 이사회 임기 종료 시 발행됩니다.

거래 후 McKeithan-Gebhardt의 총 실질 보유 주식은 직접 보유한 16,280.531주 보통주5,468.395개의 지연 주식 단위를 합쳐 약 21,749주에 달합니다. 공개 시장에서 보통주를 매수하거나 매도하지 않았으며, 현금 교환도 없었습니다; 추가 단위는 수수료 이연을 반영한 것으로 임의의 주식 구매가 아닙니다.

이번 제출서류에는 옵션 부여, 매도 또는 파생상품 처분 내역이 없으며, 내부자의 전체 소유 지분이나 회사 자본 구조에 중대한 변화가 있음을 시사하는 내용도 없습니다. SXT의 약 4,500만 주 중 약 0.002%에 불과한 소규모 거래이므로, 유동성이나 지배권 측면에서 정기적이고 중요하지 않은 거래로 간주됩니다. 다만, 긍정적인 방향의 추가 보유는 일부 투자자들에 의해 이사회가 주주 이익과 계속 일치하고 있음을 나타내는 신호로 해석될 수 있습니다.

Vue d’ensemble du dépôt du formulaire 4 – Sensient Technologies Corp. (SXT)

La directrice Deborah McKeithan-Gebhardt a déclaré une modification de routine de sa position en actions le 30 juin 2025. La transaction concernait l’acquisition de 83 054 unités d’actions différées dans le cadre du Plan de rémunération différée des administrateurs de la société. Ces unités se convertissent en actions ordinaires à raison d’une unité pour une action et seront émises à la fin du mandat de la directrice au conseil d’administration.

Suite à cette opération, la propriété bénéficiaire totale de McKeithan-Gebhardt s’élève à 16 280,531 actions ordinaires détenues directement et 5 468,395 unités d’actions différées, soit une exposition globale d’environ 21 749 actions. Aucune action ordinaire n’a été achetée ou vendue sur le marché libre, et aucune contrepartie en espèces n’a été échangée ; les unités supplémentaires reflètent un report de rémunération plutôt qu’un achat d’actions discrétionnaire.

Le dépôt ne mentionne aucune attribution d’options, vente ou cession d’instruments dérivés, et il n’y a aucun signe de changement significatif dans le pourcentage global de détention de l’initié ni dans la structure du capital de la société. Étant donné la faible taille de l’attribution (≈0,002 % des quelque 45 millions d’actions en circulation de SXT), la transaction est considérée comme routinière et non significative du point de vue de la liquidité ou du contrôle. Cependant, cette augmentation positive peut néanmoins être interprétée par certains investisseurs comme un signal d’alignement continu du conseil avec les intérêts des actionnaires.

Übersicht der Form 4-Einreichung – Sensient Technologies Corp. (SXT)

Direktorin Deborah McKeithan-Gebhardt meldete am 30. Juni 2025 eine routinemäßige Änderung ihrer Aktienposition. Die Transaktion betraf den Erwerb von 83.054 aufgeschobenen Aktienanteilen im Rahmen des Directors’ Deferred Compensation Plan des Unternehmens. Diese Einheiten werden eins zu eins in Stammaktien umgewandelt und bei Beendigung des Vorstandsmandats ausgegeben.

Nach der Transaktion hält McKeithan-Gebhardt insgesamt 16.280,531 Stammaktien direkt und 5.468,395 aufgeschobene Aktienanteile, was einer Gesamtposition von etwa 21.749 Aktien entspricht. Es wurden keine Stammaktien am offenen Markt gekauft oder verkauft, und es fand kein Geldfluss statt; die zusätzlichen Einheiten spiegeln eine Gebührenstundung wider und keinen diskretionären Aktienkauf.

Die Einreichung enthält keine Angaben zu Optionszuteilungen, Verkäufen oder Derivatveräußerungen und weist keine wesentlichen Änderungen am Gesamtbesitzanteil der Insider oder an der Kapitalstruktur des Unternehmens auf. Angesichts der geringen Größe der Zuteilung (ca. 0,002% von SXT’s etwa 45 Millionen ausstehenden Aktien) wird die Transaktion aus Liquiditäts- oder Kontrollsicht als routine und nicht wesentlich eingestuft. Dennoch könnte die tendenziell positive Ergänzung von einigen Investoren als Signal für eine fortwährende Ausrichtung des Vorstands an den Interessen der Aktionäre interpretiert werden.

Positive
  • Director increased ownership by 83.054 deferred units, reinforcing alignment with shareholders.
Negative
  • None.

Insights

TL;DR: Minor fee-deferral share credit; immaterial to valuation, mildly positive for governance optics.

The 83-share deferred stock credit increases the director’s stake to roughly 21.7 k shares, still less than 0.05 % of shares outstanding. Because no cash changed hands and there was no open-market activity, the filing has negligible impact on supply-demand dynamics or intrinsic value. Nevertheless, continued accumulation—even via automatic fee deferrals—supports a narrative of board-level alignment. I classify the disclosure as not impactful for near-term price action, but modestly positive for corporate governance sentiment.

Panoramica della presentazione del Modulo 4 – Sensient Technologies Corp. (SXT)

La direttrice Deborah McKeithan-Gebhardt ha segnalato una modifica di routine alla sua posizione azionaria in data 30 giugno 2025. L’operazione ha riguardato l’acquisizione di 83.054 unità azionarie differite nell’ambito del Piano di Compensazione Differita per i Direttori della società. Queste unità si convertono in azioni ordinarie con un rapporto uno a uno e verranno emesse al termine del mandato della direttrice nel consiglio.

Dopo questa operazione, la proprietà effettiva totale di McKeithan-Gebhardt ammonta a 16.280,531 azioni ordinarie detenute direttamente e 5.468,395 unità azionarie differite, per un’esposizione complessiva di circa 21.749 azioni. Non sono state acquistate o vendute azioni ordinarie sul mercato aperto e non è stato scambiato denaro; le unità aggiuntive riflettono un differimento delle compensazioni piuttosto che un acquisto discrezionale di azioni.

La dichiarazione non riporta alcuna concessione di opzioni, vendite o disposizioni di strumenti derivati, né indica cambiamenti significativi nella percentuale complessiva di proprietà dell’insider o nella struttura del capitale della società. Considerando la piccola entità dell’assegnazione (circa lo 0,002% delle circa 45 milioni di azioni in circolazione di SXT), l’operazione è considerata di routine e non rilevante dal punto di vista della liquidità o del controllo. Tuttavia, questo incremento positivo può comunque essere interpretato da alcuni investitori come un segnale di allineamento continuo del consiglio con gli interessi degli azionisti.

Resumen de la presentación del Formulario 4 – Sensient Technologies Corp. (SXT)

La directora Deborah McKeithan-Gebhardt reportó un cambio rutinario en su posición accionaria el 30 de junio de 2025. La transacción consistió en la adquisición de 83.054 unidades diferidas de acciones bajo el Plan de Compensación Diferida para Directores de la empresa. Estas unidades se convierten en acciones ordinarias en una proporción uno a uno y se emitirán al finalizar el servicio de la directora en el consejo.

Tras la transacción, la propiedad beneficiaria total de McKeithan-Gebhardt es de 16.280,531 acciones ordinarias poseídas directamente y 5.468,395 unidades diferidas, sumando una exposición agregada de aproximadamente 21.749 acciones. No se compraron ni vendieron acciones ordinarias en el mercado abierto, y no hubo intercambio de efectivo; las unidades adicionales reflejan un diferimiento de honorarios y no una compra discrecional de acciones.

La presentación no revela concesiones de opciones, ventas o disposiciones de derivados, y no hay indicios de cambios materiales en el porcentaje general de propiedad del insider ni en la estructura de capital de la empresa. Dado el pequeño tamaño del otorgamiento (≈0,002% de las aproximadamente 45 millones de acciones en circulación de SXT), la transacción se considera rutinaria y no material desde el punto de vista de liquidez o control. Sin embargo, esta adición positiva puede ser interpretada por algunos inversores como una señal de alineación continua del consejo con los intereses de los accionistas.

Form 4 제출 개요 – Sensient Technologies Corp. (SXT)

이사 Deborah McKeithan-Gebhardt2025년 6월 30일에 자신의 주식 보유 변동 사항을 정기적으로 보고했습니다. 이번 거래는 회사의 이사 지연 보상 계획에 따라 83.054개의 지연 주식 단위 취득을 포함합니다. 이 단위들은 1:1 비율로 보통주로 전환되며, 이사의 이사회 임기 종료 시 발행됩니다.

거래 후 McKeithan-Gebhardt의 총 실질 보유 주식은 직접 보유한 16,280.531주 보통주5,468.395개의 지연 주식 단위를 합쳐 약 21,749주에 달합니다. 공개 시장에서 보통주를 매수하거나 매도하지 않았으며, 현금 교환도 없었습니다; 추가 단위는 수수료 이연을 반영한 것으로 임의의 주식 구매가 아닙니다.

이번 제출서류에는 옵션 부여, 매도 또는 파생상품 처분 내역이 없으며, 내부자의 전체 소유 지분이나 회사 자본 구조에 중대한 변화가 있음을 시사하는 내용도 없습니다. SXT의 약 4,500만 주 중 약 0.002%에 불과한 소규모 거래이므로, 유동성이나 지배권 측면에서 정기적이고 중요하지 않은 거래로 간주됩니다. 다만, 긍정적인 방향의 추가 보유는 일부 투자자들에 의해 이사회가 주주 이익과 계속 일치하고 있음을 나타내는 신호로 해석될 수 있습니다.

Vue d’ensemble du dépôt du formulaire 4 – Sensient Technologies Corp. (SXT)

La directrice Deborah McKeithan-Gebhardt a déclaré une modification de routine de sa position en actions le 30 juin 2025. La transaction concernait l’acquisition de 83 054 unités d’actions différées dans le cadre du Plan de rémunération différée des administrateurs de la société. Ces unités se convertissent en actions ordinaires à raison d’une unité pour une action et seront émises à la fin du mandat de la directrice au conseil d’administration.

Suite à cette opération, la propriété bénéficiaire totale de McKeithan-Gebhardt s’élève à 16 280,531 actions ordinaires détenues directement et 5 468,395 unités d’actions différées, soit une exposition globale d’environ 21 749 actions. Aucune action ordinaire n’a été achetée ou vendue sur le marché libre, et aucune contrepartie en espèces n’a été échangée ; les unités supplémentaires reflètent un report de rémunération plutôt qu’un achat d’actions discrétionnaire.

Le dépôt ne mentionne aucune attribution d’options, vente ou cession d’instruments dérivés, et il n’y a aucun signe de changement significatif dans le pourcentage global de détention de l’initié ni dans la structure du capital de la société. Étant donné la faible taille de l’attribution (≈0,002 % des quelque 45 millions d’actions en circulation de SXT), la transaction est considérée comme routinière et non significative du point de vue de la liquidité ou du contrôle. Cependant, cette augmentation positive peut néanmoins être interprétée par certains investisseurs comme un signal d’alignement continu du conseil avec les intérêts des actionnaires.

Übersicht der Form 4-Einreichung – Sensient Technologies Corp. (SXT)

Direktorin Deborah McKeithan-Gebhardt meldete am 30. Juni 2025 eine routinemäßige Änderung ihrer Aktienposition. Die Transaktion betraf den Erwerb von 83.054 aufgeschobenen Aktienanteilen im Rahmen des Directors’ Deferred Compensation Plan des Unternehmens. Diese Einheiten werden eins zu eins in Stammaktien umgewandelt und bei Beendigung des Vorstandsmandats ausgegeben.

Nach der Transaktion hält McKeithan-Gebhardt insgesamt 16.280,531 Stammaktien direkt und 5.468,395 aufgeschobene Aktienanteile, was einer Gesamtposition von etwa 21.749 Aktien entspricht. Es wurden keine Stammaktien am offenen Markt gekauft oder verkauft, und es fand kein Geldfluss statt; die zusätzlichen Einheiten spiegeln eine Gebührenstundung wider und keinen diskretionären Aktienkauf.

Die Einreichung enthält keine Angaben zu Optionszuteilungen, Verkäufen oder Derivatveräußerungen und weist keine wesentlichen Änderungen am Gesamtbesitzanteil der Insider oder an der Kapitalstruktur des Unternehmens auf. Angesichts der geringen Größe der Zuteilung (ca. 0,002% von SXT’s etwa 45 Millionen ausstehenden Aktien) wird die Transaktion aus Liquiditäts- oder Kontrollsicht als routine und nicht wesentlich eingestuft. Dennoch könnte die tendenziell positive Ergänzung von einigen Investoren als Signal für eine fortwährende Ausrichtung des Vorstands an den Interessen der Aktionäre interpretiert werden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McKeithan Gebhardt Deborah

(Last) (First) (Middle)
777 EAST WISCONSIN AVENUE

(Street)
MILWAUKEE WI 53202

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SENSIENT TECHNOLOGIES CORP [ SXT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 16,280.531(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock (2) 06/30/2025 A(3) 83.054 (4) (4) Common Stock 83.054 $0 5,468.395 D
Explanation of Responses:
1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
2. Deferred stock converts to common stock on a one-for-one basis.
3. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.
4. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.
/s/ John J. Manning, Attorney-in-Fact for Ms. McKeithan-Gebhardt 07/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Sensient Technologies (SXT) shares does Director Deborah McKeithan-Gebhardt now own?

16,280.531 common shares plus 5,468.395 deferred stock units, totalling about 21,749 equivalent shares.

What type of transaction was reported in the Form 4 for SXT?

An acquisition (A) of 83.054 deferred stock units through the Director fee deferral plan.

Did the director buy or sell SXT shares on the open market?

No. The filing reflects a non-cash fee deferral; there was no market purchase or sale.

When will the deferred stock units convert to SXT common stock?

They convert one-for-one upon termination of the director’s board service.

Is the reported transaction material to SXT shareholders?

Given it represents roughly 0.002 % of outstanding shares, the impact is considered immaterial.
Sensient Tech

NYSE:SXT

SXT Rankings

SXT Latest News

SXT Latest SEC Filings

SXT Stock Data

4.17B
41.77M
1.56%
91.76%
1.18%
Specialty Chemicals
Industrial Organic Chemicals
Link
United States
MILWAUKEE